overview of 3 studies on cll therapy: data on ibrutinib and a ror1 inhibitor
Published 8 years ago • 760 plays • Length 3:28Download video MP4
Download video MP3
Similar videos
-
3:46
the characteristics and mode of action of ibrutinib for cll
-
5:52
understanding ultra high-risk cll and advances with ibrutinib therapy
-
2:58
results of a phase ib study of ibrutinib obinutuzumab in r/r cll
-
1:38
front-line use of ibrutinib for cll in a real-world setting
-
9:00
overview of cll therapies and sequencing of therapies
-
5:33
what are the stages of cll? #cll
-
4:08
what is chronic lymphocytic leukemia #cll?
-
14:31
chronic lymphocytic leukemia -- cancer guide
-
2:06
the role of ibrutinib in the frontline treatment of young patients with cll
-
1:05
final analysis of the alpine trial: zanubrutinib vs ibrutinib in r/r cll
-
1:23
interim analysis of the flair study: efficacy of ibrutinib plus venetoclax in ighv unmutated cll
-
1:28
overview of resonate-2 clinical trial of ibrutinib in cll
-
0:49
overview of the cll2-big trial of ibrutinib and obinutuzumab
-
2:14
ibrutinib's role in cll treatment and future outlooks
-
4:11
the mechanism of ibrutinib in cll treatment
-
2:06
effects of dose adjustment of first-line ibrutinib on real-world dosing patterns and outcomes in cll
-
2:39
the safety and efficacy of ibrutinib for the treatment of cll
-
3:29
how the management of cll is evolving
-
2:18
first-line ibrutinib and venetoclax in cll
-
2:17
updated analysis of bellwave-001: nemtabrutinib in r/r cll
-
4:43
phase ib trial of ianalumab plus ibrutinib for cll
-
2:21
uk-based cll clinical trials to look forward to